SATORI PHARMACEUTICALS INC — Form D
SATORI PHARMACEUTICALS INC of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2011-01-03. The offering totals $20.7M, of which $7.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2011-01-03
- Form: D
- Accession: 0001329516-11-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $20.7M
- Amount sold: $7.0M
- Remaining: $13.7M
- Investors: 3
- Date of first sale: 2010-12-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-152876
Issuer
- Name: SATORI PHARMACEUTICALS INC
- CIK: 0001329516
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 281 ALBANY STREET, CAMBRIDGE, MA, 02139
- Phone: 6175470661
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Christopher Ehrlich | Director | Cambridge, MA |
| Steven Holtzman | Director | BOSTON, MA |
| Ilan Zipkin | Director | OAKLAND, CA |
| Daphne Zohar | Director | Boston, MA |
| Edward Mathers | Director | South San Francisco, CA |
| Chris Ehrlich | Director | South San Francisco, CA |
| Bennett Shapiro | Director | Cambridge, MA |
| Jeffrey Ives | Director | Groton, CT |
| Jeffrey Ives | Executive Officer | Groton, CT |
| David Schnell | Director | New York, NY |
| Stephen Muniz | Director | Cambridge, MA |
Other filings by this issuer (2)
More